These data were confirmed by another study, which also revealed that DHA treatment in prostate cancer cells down-regulated UHRF1 expression and induced the expression of p16INK4A, which led to decreased proliferation and metastasis, while enhancing apoptosis [114]. This evidence concerns the gene UHRF1 and prostate carcinoma.